TNF and myositis disease: Drug-induced myositis has also been rarely described after anti-TNF alpha treatment (to the best of the authors’ knowledge 58 cases have been found throughout literature), suggesting a non-class-specific phenomenon (Zhou et al., 2015; Gaboriau et al., 2020; Yoshida et al., 2021; Jordan et al., 2022; Zengin et al., 2017; Chavarría-Miranda et al., 2021; Mukharesh and Tinsley, 2022; Kato et al., 2014; Caramaschi et al., 2003).